Musculoskeletal manifestations in a cohort of Beh��et's disease patients and their impact on health-related quality of life.

Samar Tharwat, Nasim Jaber, Hamza Aljubaeh, Omar Abumunshar
Author Information
  1. Samar Tharwat: Rheumatology and Immunology Unit, Department of Internal Medicine, Faculty of Medicine, Mansoura University Hospital, Mansoura University, El Gomhouria St, Mansoura, 35511, Dakahlia Governorate, Egypt. samartharwat2000@mans.edu.eg. ORCID
  2. Nasim Jaber: Faculty of Medicine, Mansoura University, Mansoura, Egypt.
  3. Hamza Aljubaeh: Faculty of Medicine, Mansoura University, Mansoura, Egypt.
  4. Omar Abumunshar: Faculty of Medicine, Mansoura University, Mansoura, Egypt.

Abstract

Beh��et's disease (BD) is a multifaceted disorder of undetermined etiology. Distinct clinical manifestations exhibit varying prevalences, with mucocutaneous and ocular presentations being the most prevalent in the BD population. The aim of this study was to assess musculoskeletal (MSK) manifestations and their effect on health-related quality of life (HRQoL) of life in individuals with BD. We asked patients with BD to complete an online survey. The survey had many questions focused on demographic, clinical, and therapeutic data, as well as the Nordic musculoskeletal questionnaire and the short form-36 (SF-36). There was a total of 185 BD patients, mostly females (54.6%), with a mean age of 33.81 years. The most prevalent clinical manifestation was recurrent oral aphthosis (95.1%), followed by ocular involvement (72.4%). Most of the study patients (85.4%) reported MSK manifestations in the last 6 months. These manifestations included mainly the lower back (69%) and neck (67%), followed by the left and right knees (62% and 60%, respectively), while the least affected areas of the body were the right elbow (37%), and the right ankle and foot (7%). The age at disease onset (p���=���0.007) showed a statistically significant difference between those with MSK manifestations and those without. patients exhibiting MSK manifestations demonstrated statistically significant lower scores of all SF-36 domains compared to those without such manifestations. MSK manifestations are prevalent and adversely affect HRQoL among BD patients. Therefore, early identification and treatment are strongly recommended.

Keywords

References

  1. Sakane T, Takeno M, Suzuki N, Inaba G (1999) Beh��et���s disease. N Engl J Med 341:1284���1291. https://doi.org/10.1056/NEJM199910213411707 [DOI: 10.1056/NEJM199910213411707]
  2. Yurdakul S (2020) Epidemiology of Beh��et syndrome and regional differences in disease expression. In: Yazici Y, Hatemi G, Seyahi E, Yazici H (eds) Beh��et syndrome. Springer International Publishing, Cham, pp 21���35 [DOI: 10.1007/978-3-030-24131-5_3]
  3. Hirohata T, Kuratsune M, Nomura A, Jimi S (1975) Prevalence of Beh��et���s syndrome in Hawaii. With particular reference to the comparison of the Japanese in Hawaii and Japan. Hawaii Med J 34:244���246 [PMID: 1165185]
  4. Madanat WY, Alawneh KM, Smadi MM et al (2017) The prevalence of Beh��et���s disease in the north of Jordan: a hospital-based epidemiological survey. Clin Exp Rheumatol 35(Suppl 108):51���54 [PMID: 29224587]
  5. Yazici H, Fresko I, Yurdakul S (2007) Beh��et���s syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 3:148���155. https://doi.org/10.1038/ncprheum0436 [DOI: 10.1038/ncprheum0436]
  6. Li C, Li L, Wu X et al (2020) Clinical manifestations of Beh��et���s disease in a large cohort of Chinese patients: gender- and age-related differences. Clin Rheumatol 39:3449���3454. https://doi.org/10.1007/s10067-020-05026-2 [DOI: 10.1007/s10067-020-05026-2]
  7. Mendes D, Correia M, Barbedo M et al (2009) Beh��et���s disease���a contemporary review. J Autoimmun 32:178���188. https://doi.org/10.1016/j.jaut.2009.02.011 [DOI: 10.1016/j.jaut.2009.02.011]
  8. Fatemi A, Shahram F, Akhlaghi M et al (2017) Prospective study of articular manifestations in Beh��et���s disease: five-year report. Int J Rheum Dis 20:97���102. https://doi.org/10.1111/1756-185X.12633 [DOI: 10.1111/1756-185X.12633]
  9. K��tter I, L��tscher F (2021) Beh��et���s syndrome apart from the triple symptom complex: vascular, neurologic, gastrointestinal, and musculoskeletal manifestations. A mini review. Front Med 8:639758. https://doi.org/10.3389/fmed.2021.639758 [DOI: 10.3389/fmed.2021.639758]
  10. Dawson AP, Steele EJ, Hodges PW, Stewart S (2009) Development and test-retest reliability of an extended version of the Nordic Musculoskeletal Questionnaire (NMQ-E): a screening instrument for musculoskeletal pain. J Pain 10:517���526. https://doi.org/10.1016/j.jpain.2008.11.008 [DOI: 10.1016/j.jpain.2008.11.008]
  11. Tharwat S, Husain SM (2024) Musculoskeletal symptoms in systemic lupus erythematosus patients and their impact on health-related quality of life. BMC Musculoskelet Disord 25:272. https://doi.org/10.1186/s12891-024-07367-4 [DOI: 10.1186/s12891-024-07367-4]
  12. Tharwat S, Nassar MK (2024) Musculoskeletal symptoms and their impact on health-related quality of life in chronic nonbacterial osteomyelitis patients. Pediatr Rheumatol Online J 22:34. https://doi.org/10.1186/s12969-024-00971-7 [DOI: 10.1186/s12969-024-00971-7]
  13. Bicer A (2011) Musculoskeletal findings in Behcet���s disease. Pathol Res Int 2012:653806. https://doi.org/10.1155/2012/653806 [DOI: 10.1155/2012/653806]
  14. Pugh JD, Gelder L, Williams AM et al (2015) Validity and reliability of an online extended version of the Nordic Musculoskeletal Questionnaire (NMQ-E2) to measure nurses��� fitness. J Clin Nurs 24:3550���3563. https://doi.org/10.1111/jocn.12971 [DOI: 10.1111/jocn.12971]
  15. Pinquart M (2020) Health-related quality of life of young people with and without chronic conditions. J Pediatr Psychol 45:780���792. https://doi.org/10.1093/jpepsy/jsaa052 [DOI: 10.1093/jpepsy/jsaa052]
  16. Canpolat O, Yurtsever S (2011) The quality of life in patients with Beh��et���s disease. Asian Nurs Res 5:229���235. https://doi.org/10.1016/j.anr.2011.12.003 [DOI: 10.1016/j.anr.2011.12.003]
  17. Onal S, Savar F, Akman M, Kazokoglu H (2010) Vision- and health-related quality of life in patients with Beh��et uveitis. Arch Ophthalmol Chic Ill 1960 128:1265���1271. https://doi.org/10.1001/archophthalmol.2010.209 [DOI: 10.1001/archophthalmol.2010.209]
  18. Mastrolia MV, Marinello D, di Cianni F, et al (2022). Assessing quality of life in Beh��et���s disease: a systematic review. Clin Exp Rheumatol. 40:1560���1566. https://doi.org/10.55563/clinexprheumatol/sian1b
  19. International Team for the Revision of the International Criteria for Beh��et���s Disease (ITR-ICBD) (2014) The International Criteria for Beh��et���s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol JEADV 28:338���347. https://doi.org/10.1111/jdv.12107 [DOI: 10.1111/jdv.12107]
  20. Kuorinka I, Jonsson B, Kilbom A et al (1987) Standardised Nordic questionnaires for the analysis of musculoskeletal symptoms. Appl Ergon 18:233���237. https://doi.org/10.1016/0003-6870(87)90010-x [DOI: 10.1016/0003-6870(87)90010-x]
  21. Aldhabi R, Albadi M, Kahraman T, Alsobhi M (2024) Cross-cultural adaptation, validation and psychometric properties of the Arabic version of the Nordic Musculoskeletal Questionnaire in office working population from Saudi Arabia. Musculoskelet Sci Pract 72:103102. https://doi.org/10.1016/j.msksp.2024.103102 [DOI: 10.1016/j.msksp.2024.103102]
  22. AboAbat A, Qannam H, Bjorner JB, Al-Tannir M (2020) Psychometric validation of a Saudi Arabian version of the sf-36v2 health survey and norm data for Saudi Arabia. J Patient-Rep Outcomes 4:67. https://doi.org/10.1186/s41687-020-00233-6 [DOI: 10.1186/s41687-020-00233-6]
  23. Davatchi F, Shahram F, Chams-Davatchi C et al (2010) Behcet���s disease: from East to West. Clin Rheumatol 29:823���833. https://doi.org/10.1007/s10067-010-1430-6 [DOI: 10.1007/s10067-010-1430-6]
  24. Lin Y-H, Tai T-Y, Pu C-Y et al (2018) Epidemiology of Behcet���s disease in Taiwan: a population-based study. Ophthalmic Epidemiol 25:323���329. https://doi.org/10.1080/09286586.2018.1469157 [DOI: 10.1080/09286586.2018.1469157]
  25. Cansu D��, Ka��ifo��lu T, Korkmaz C (2016) Do clinical findings of Beh��et���s disease vary by gender?: a single-center experience from 329 patients. Eur J Rheumatol 3:157���160. https://doi.org/10.5152/eurjrheum.2016.038 [DOI: 10.5152/eurjrheum.2016.038]
  26. Thomas T, Chandan JS, Subramanian A et al (2020) Epidemiology, morbidity and mortality in Beh��et���s disease: a cohort study using the Health Improvement Network (THIN). Rheumatol Oxf Engl 59:2785���2795. https://doi.org/10.1093/rheumatology/keaa010 [DOI: 10.1093/rheumatology/keaa010]
  27. Bonitsis NG, Luong Nguyen LB, LaValley MP et al (2015) Gender-specific differences in Adamantiades-Beh��et���s disease manifestations: an analysis of the German registry and meta-analysis of data from the literature. Rheumatol Oxf Engl 54:121���133. https://doi.org/10.1093/rheumatology/keu247 [DOI: 10.1093/rheumatology/keu247]
  28. Mahr A, Maldini C (2014) Epidemiology of Beh��et���s disease. Rev Med Interne 35:81���89. https://doi.org/10.1016/j.revmed.2013.12.005 [DOI: 10.1016/j.revmed.2013.12.005]
  29. Lee YB, Lee SY, Choi JY et al (2018) Incidence, prevalence, and mortality of Adamantiades-Beh��et���s disease in Korea: a nationwide, population-based study (2006���2015). J Eur Acad Dermatol Venereol JEADV 32:999���1003. https://doi.org/10.1111/jdv.14601 [DOI: 10.1111/jdv.14601]
  30. Vaiopoulos AG, Kanakis MA, Kapsimali V et al (2016) Juvenile Adamantiades-Beh��et disease. Dermatol Basel Switz 232:129���136. https://doi.org/10.1159/000442667 [DOI: 10.1159/000442667]
  31. Salvarani C, Pipitone N, Catanoso MG et al (2007) Epidemiology and clinical course of Beh��et���s disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study. Arthritis Rheum 57:171���178. https://doi.org/10.1002/art.22500 [DOI: 10.1002/art.22500]
  32. Caporn N, Higgs ER, Dieppe PA, Watt I (1983) Arthritis in Behcet���s syndrome. Br J Radiol 56:87���91. https://doi.org/10.1259/0007-1285-56-662-87 [DOI: 10.1259/0007-1285-56-662-87]
  33. Davatchi F, Shahram F, Chams-Davatchi C et al (2010) Behcet���s disease in Iran: analysis of 6500 cases. Int J Rheum Dis 13:367���373. https://doi.org/10.1111/j.1756-185X.2010.01549.x [DOI: 10.1111/j.1756-185X.2010.01549.x]
  34. Chamberlain MA (1977) Behcet���s syndrome in 32 patients in Yorkshire. Ann Rheum Dis 36:491���499. https://doi.org/10.1136/ard.36.6.491 [DOI: 10.1136/ard.36.6.491]
  35. Yavuz S, Fresko I, Hamuryudan V et al (1998) Fibromyalgia in Beh��et���s syndrome. J Rheumatol 25:2219���2220 [PMID: 9818667]
  36. Dilsen N, Konice M, Ovul C (1979) Arthritic patterns in Beh��et���s disease. Beh��s Dis Amst Oxf Excerpta Medica 145���55
  37. Olivieri I, Gemignani G, Camerini E et al (1990) Computed tomography of the sacroiliac joints in four patients with Beh��et���s syndrome���confirmation of sacroiliitis. Br J Rheumatol 29:264���267. https://doi.org/10.1093/rheumatology/29.4.264 [DOI: 10.1093/rheumatology/29.4.264]
  38. Chang HK, Lee DH, Jung SM et al (2002) The comparison between Beh��et���s disease and spondyloarthritides: does Beh��et���s disease belong to the spondyloarthropathy complex? J Korean Med Sci 17:524���529. https://doi.org/10.3346/jkms.2002.17.4.524 [DOI: 10.3346/jkms.2002.17.4.524]
  39. Kotevoglu N, Tasbas I, Bekiroglu N (2004) Computed tomography does not support sacroiliitis as a feature of beh��et disease: a metaanalytic review. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis 10:42���45. https://doi.org/10.1097/01.rhu.0000111298.67743.08 [DOI: 10.1097/01.rhu.0000111298.67743.08]
  40. Hatemi G, Bahar H, Uysal S et al (2004) The pustular skin lesions in Behcet���s syndrome are not sterile. Ann Rheum Dis 63:1450���1452. https://doi.org/10.1136/ard.2003.017467 [DOI: 10.1136/ard.2003.017467]
  41. Yazici Y, Hatemi G, Bodaghi B et al (2021) Beh��et syndrome. Nat Rev Dis Primer 7:67. https://doi.org/10.1038/s41572-021-00301-1 [DOI: 10.1038/s41572-021-00301-1]
  42. Mazzoccoli G, Matarangolo A, Rubino R et al (2016) Beh��et syndrome: from pathogenesis to novel therapies. Clin Exp Med 16:1���12. https://doi.org/10.1007/s10238-014-0328-z [DOI: 10.1007/s10238-014-0328-z]
  43. Manav V, ��lhan D, Mercan H et al (2022) Association between intervertebral disc degeneration and Beh��et���s disease. Dermatol Ther 35:e15585. https://doi.org/10.1111/dth.15585 [DOI: 10.1111/dth.15585]
  44. Komatsumoto M, Kono M, Shimizu Y (2021) A case of Beh��et���s syndrome initially presenting as recurrent neck pain. Rheumatol Oxf Engl 60:e12���e13. https://doi.org/10.1093/rheumatology/keaa376 [DOI: 10.1093/rheumatology/keaa376]
  45. Hatemi G, Fresko I, Yurdakul S et al (2010) Reply to letter by Priori et al commenting on whether Beh��et���s syndrome patients with acne and arthritis comprise a true subset. Arthritis Rheum 62:305���306. https://doi.org/10.1002/art.27181 [DOI: 10.1002/art.27181]
  46. Ceccarelli F, Priori R, Iagnocco A et al (2007) Knee joint synovitis in Beh��et���s disease: a sonographic study. Clin Exp Rheumatol 25:S76-79 [PMID: 17949556]
  47. Jo YG, Ortiz-Fern��ndez L, Coit P et al (2022) Sex-specific analysis in Beh��et���s disease reveals higher genetic risk in male patients. J Autoimmun 132:102882. https://doi.org/10.1016/j.jaut.2022.102882 [DOI: 10.1016/j.jaut.2022.102882]
  48. Yao W, Luo C, Ai F, Chen Q (2012) Risk factors for nonspecific low-back pain in Chinese adolescents: a case-control study. Pain Med Malden Mass 13:658���664. https://doi.org/10.1111/j.1526-4637.2012.01369.x [DOI: 10.1111/j.1526-4637.2012.01369.x]
  49. Khabbazi A, Ebrahimzadeh Attari V, Asghari Jafarabadi M, Malek Mahdavi A (2021) Quality of life in patients with Beh��et disease and its relation with clinical symptoms and disease activity. Reumatol Clin 17:1���6. https://doi.org/10.1016/j.reuma.2019.03.002 [DOI: 10.1016/j.reuma.2019.03.002]
  50. Bernab�� E, Marcenes W, Mather J et al (2010) Impact of Beh��et���s syndrome on health-related quality of life: influence of the type and number of symptoms. Rheumatol Oxf Engl 49:2165���2171. https://doi.org/10.1093/rheumatology/keq251 [DOI: 10.1093/rheumatology/keq251]

Word Cloud

Created with Highcharts 10.0.0manifestationsBDMSKpatientsdiseaselifeclinicalprevalentqualityrightBeh��et'socularstudymusculoskeletalhealth-relatedHRQoLsurveySF-36agefollowed4%lowerstatisticallysignificantwithoutMusculoskeletalmultifaceteddisorderundeterminedetiologyDistinctexhibitvaryingprevalencesmucocutaneouspresentationspopulationaimassesseffectindividualsaskedcompleteonlinemanyquestionsfocuseddemographictherapeuticdatawellNordicquestionnaireshortform-36total185mostlyfemales546%mean3381yearsmanifestationrecurrentoralaphthosis951%involvement7285reportedlast6 monthsincludedmainlyback69%neck67%leftknees62%60%respectivelyleastaffectedareasbodyelbow37%anklefoot7%onsetp���=���0007showeddifferencePatientsexhibitingdemonstratedscoresdomainscomparedadverselyaffectamongThereforeearlyidentificationtreatmentstronglyrecommendedcohortimpactBeh��et���sHealth-relatedPain

Similar Articles

Cited By

No available data.